• Nuclear Medicine and Molecular Imaging
• /
• v.41 no.4
• /
• pp.265-271
• /
• 2007

Radionuclide therapy has been an important field in nuclear medicine. In radionuclide therapy, relevant evaluation of Internally absorbed dose is essential for the achievement of efficient and sufficient treatment of incurable disease, and can be accomplish by means of accurate measurement of radioactivity in body and its changes with time. Recently, the advances of nuclear medicine imaging and multi modality imaging processing techniques can provide change of more accurate and easier measurement of the measures commented above, in cooperation of conventional imaging based approaches. in this review, basic concept for internal dosimetry using nuclear medicine imaging is summarized with several check points which should be considered In real practice.

• Nuclear Engineering and Technology
• /
• v.50 no.3
• /
• pp.526-530
• /
• 2018

Human fingernails were used to estimate the radiation dose via electron paramagnetic resonance measurements of radiation-induced radicals. The limiting factors in this research were mechanically induced electron paramagnetic resonance signals due to the mechanical stress during the preparation of the samples. Therefore, different treatment methods of fingernails were used to reduce the mechanically induced signals. The results demonstrate that the mechanically induced and radiation-induced signals have apparently different microwave power saturation behaviors. In addition, the mechanically induced signal shows a fading evolution over time and reaches a constant value. Chemical treatment using the different reagents showed that the minimum mechanically induced signal was obtained using the dithiothreitol reagent. The dose-response curves of the samples treated with dithiothreitol for 30 minutes demonstrated a greater linearity than those of samples treated for 5 minutes. Therefore, to find an unknown absorbed dose in a fingernail sample using a calibration curve, we recommend adopting the mentioned chemical treatment procedure to reduce the uncertainty.

• Progress in Medical Physics
• /
• v.9 no.3
• /
• pp.185-192
• /
• 1998

It is necessarily to evaluate the energy of X-ray emitted from linear accelerator in order to determine the accurate absorbed dose. The method of direct measurement for x-ray energy is very difficult and impractical. Therefore the method of using beam quality index is generally used. Several dosimetry protocols recommend the use of quality indices such as depth of dose maximum at radiation central axis, dose gradient, and dose level. The linear accelerator manufactures follow the recommendation as dosimetry protocols. The study was performed for us to select the most suitable parameter among the Quality indices as described above. For photon beams of 4, 6, 10, 15, and 21 MV nominal energies produced by four kinds of accelerators(Mitsubishi, Scanditronix, Siemens, Varian) in eleven institutions, We evaluated the x-ray energies obtained by the Quality indices as recommended by several dosimetry protocols and manufactures. Results showed that there were energy spreads according to the same accelerators and Quality indices even though nominal energies were same. It appeared that the percent depth dose at 10 cm (D$_{10}$(%)) gave the smallest deviation and spread of energies. As energies increased, the energy deviation increased for all the quality indices. It is desirable for the use of unified quality index to compare the evaluation of beam quality at different institutions.

• Journal of radiological science and technology
• /
• v.21 no.2
• /
• pp.43-46
• /
• 1998

When a patient was irradiated with prosthetic hip, the dose distribution was changed according to inhomogeneous materials. The density, effective atomic number, and the composition of material had influence on absorbed dose distribution. In this study, the influence of inhomogeneous material(Ti) was measured using a polyethylene phantom, which consisted of various diameter of titanium, with film dosimetry. As a result, the backward dose showed 29.5% increas by backscattering, the forward dose showed 28% decreas by absorption, and the side dose showed 7% increas by scattering, when 25 mm diameter Ti was used. In addition forward dose was in inverse proportion to the thickness of prosthetic material. When the prosthetic hip of patient is in an irradiated field, we must carefully study the absorbed dose distribution.

• Radiation Oncology Journal
• /
• v.10 no.1
• /
• pp.115-120
• /
• 1992

A mathematical model is presented for the calculation of the depth absorbed dose in water Phantom irradiated by high energy Photon beam (10MV X-ray), based on transport theory. The parameters of this model are obtained from the experimental values which were simulated by non-linear regression process method. The calculated absorbed dose distribution is extended to 3-D by using trial function from beam profile field sizes, SSD and depth in water phantom irradiated by high energy Photon beam. The calculated values using this model are in good agreement with the measured values.

• The Journal of the Korean dental association
• /
• v.50 no.7
• /
• pp.420-430
• /
• 2012

Purpose: The purpose of this study was to measure the absorbed dose and to calculate the effective dose for full-mouth periapical radiography using the portable dental x-ray machine and panoramic radiography Material and Method: Thermoluminescent chips were placed at 25sites throughout the layers of the head and neck of a tissue-equivalent human skull phantom. The man phantom was exposed with the portable dental x-ray machine and panoramic unit. During full-mouth periapical radiography the exposure setting was 60 kVp, 2 mA and 0.15 ~ 0.25 seconds, while during panoramic radiography the selected exposure setting was 72 kVp, 8 mA and 18 seconds. Absorbed dose measurements were obtained and equivalent doses to individual organs were summed using ICRP 103 to calculate of effective dose. Result: In the full-mouth periapical radiography, the highest absorbed dose was recorded at the mandible body follow with submandibular glands and cheek. Using panoramic unit, the highest absorbed dose was parotid glands and the following was back of neck and submandibular glands. The effective dose in full-mouth periapical radiography using portable dental x-ray machine was 46 ${\mu}Sv$. In panoramic radiography, the effective dose was 38 ${\mu}pSv$. Conclusion: It was recommended to panoramic radiography for general check in the head and neck area because that the effect dose in the panoramic radiography was lower than the dose in the full-mouth periapical radiography using portable dental x-ray machine.

• Journal of Radiation Protection and Research
• /
• v.11 no.1
• /
• pp.77-82
• /
• 1986

Determination of the relation between the kerma(Kinetic Energy Released in Material) and the absorbed dose is one of the basic problems of dosimetry. Kerma and absorbed dose were measured for 6 MV X-ray from the high energy medical linear accelerator and $^{60}Co$ gamma-ray. The experimental results show that the absorbed dose in the transient equilibrium region practically coincide with the kerma in water and Al for $^{60}Co$. The maximum dose depths were $1.45g/cm^2$ for 6MV X-ray and $0.48g/cm^2\;for\;^{60}Co$ gamma-ray. The ratios of the absorbed dose at maximum build-up to the collision kerma at the surface, ($K^{att}$), were 0.949 for 6MV X-ray and 0.992 for $^{60}Co$ gamma-ray. No difference was found between water and Al when the standard field size was used. This results show that the dependence of $K^{att}$ on the material is very small.

• Progress in Medical Physics
• /
• v.24 no.3
• /
• pp.140-144
• /
• 2013

In this research, the glass dosimeter was calibrated to measure the standard absorbed dose of the Cs-137 irradiator and absorbed dose in a biological sample. Absorbed dose in water for Cs-137 gamma ray was determined by the IAEA TRS-277 protocol. The PTW-TM30013 ion chamber and the PTW-TM41023 water phantom were utilized for measuring absorbed dose and the value was compared with the reading from DoseAce GD-302M glass dosimeter from Asahi Techno Glass Corporation for its calibration. The uncertainty of measurement ($1{\sigma}$) of the calibrated glass dosimeter was 2.7% and this result would be applied to improve the accuracy in measurement of absorbed dose in a biological sample.

• Korean Journal of Digital Imaging in Medicine
• /
• v.14 no.2
• /
• pp.15-22
• /
• 2012

The purpose of this study was to measure the absorbed dose and calculate the effective dose for cone beam computed tomography (CBCT) and panorama units and to estimate usefulness of x-ray protective. Rando phantom and glass dosimeters were used for dosimetry. The absorbed doses were measured at 15 organs and 14 remainder from correspond to ICRP 2007 recommendations. The absorbed dose was highest in salivary glands as measured CBCT 2.420mGy, panorama 0.307mGy. Absorbed dose in another organs were high in order of thyroid, brain, skin, esophagus. The effective dose was CBCT 0.100mSv, panorama 0.011mSv and effective dose of panorama was higher than that of CBCT by 10 times. In case of wearing x-ray protective, reducing effective dose of CBCT by 0.066mSv (66%) and panorama by 0.008mSv (72%). Effective dose were reduced by radiological shielding but it needs further optimization studies, where dosimetric data are analyzed in combination with image quality with keep the patients' exposure as low as possible.

• Korean Journal of Radiology
• /
• v.25 no.2
• /
• pp.179-188
• /
• 2024

Objective: ¹⁷⁷Lutetium [Lu] Ludotadipep is a novel prostate-specific membrane antigen targeting therapeutic agent with an albumin motif added to increase uptake in the tumors. We assessed the biodistribution and dosimetry of [¹⁷⁷Lu]Ludotadipep in patients with metastatic castration-resistant prostate cancer (mCRPC). Materials and Methods: Data from 25 patients (median age, 73 years; range, 60-90) with mCRPC from a phase I study with activity escalation design of single administration of [¹⁷⁷Lu]Ludotadipep (1.85, 2.78, 3.70, 4.63, and 5.55 GBq) were assessed. Activity in the salivary glands, lungs, liver, kidneys, and spleen was estimated from whole-body scan and abdominal SPECT/CT images acquired at 2, 24, 48, 72, and 168 h after administration of [¹⁷⁷Lu]Ludotadipep. Red marrow activity was calculated from blood samples obtained at 3, 10, 30, 60, and 180 min, and at 24, 48, and 72 h after administration. Organand tumor-based absorbed dose calculations were performed using IDAC-Dose 2.1. Results: Absorbed dose coefficient (mean ± standard deviation) of normal organs was 1.17 ± 0.81 Gy/GBq for salivary glands, 0.05 ± 0.02 Gy/GBq for lungs, 0.14 ± 0.06 Gy/GBq for liver, 0.77 ± 0.28 Gy/GBq for kidneys, 0.12 ± 0.06 Gy/GBq for spleen, and 0.07 ± 0.02 Gy/GBq for red marrow. The absorbed dose coefficient of the tumors was 10.43 ± 7.77 Gy/GBq. Conclusion: [¹⁷⁷Lu]Ludotadipep is expected to be safe at the dose of 3.7 GBq times 6 cycles planned for a phase II clinical trial with kidneys and bone marrow being the critical organs, and shows a high tumor absorbed dose.